The only available text to focus primarily on Acute Respiratory Distress Syndrome (ARDS). Thoroughly revised content and ten new chapters provide pulmonologists with the latest developments and applications of pharmacological and mechanical therapies needed to treat the debilitating and difficult condition of ARDS. Highlights include: the definition, epidemiology, pathology, and pathogenesis of ARDS complications such as transfusion-related injury, and endothelium and vascular dysfunction the long-term outcomes of ARDS host defense and infection the latest developments in ARDS therapy: glucocorticoid therapy, surfactant therapy, mechanical ventilation, and mesenchymal stem cells predictive factors: gene expression profiling and biomarkers, and chemokines and cytokines advances in management strategies: fluid management, non-pulmonary and non-sepsis management, and glucose control

The only available text to focus primarily on Acute Respiratory Distress Syndrome (ARDS).

Thoroughly revised content and ten new chapters provide pulmonologists with the latest developments and applications of pharmacological and mechanical therapies needed to treat the debilitating and difficult condition of ARDS.
Key features:
REVISION OF A BESTSELLER-Updated content and ten new chapters cover the latest developments and applications physicians need to treat ARDS
EVALUATION OF CURRENT THERAPIES-Surfactant therapy, glucocorticoid therapy, invasive and non-invasive prone position forms of mechanical ventilation, and mesenchymal stem cells helps clinicians give patients the best possible care
INTERNATIONAL TEAM OF EDITORS AND CONTRIBUTORS-Key opinion leaders with diverse backgrounds and experience provide authoritative guidance physicians want and trust
A COMPLETE STAND-ALONE GUIDE-the only available comprehensive volume to tackle this pertinent issue and cover both its pathophysiology and pathogens